What We Do
Our objective is to enable our partners to continue to develop their most important drug candidates without increasing the burden on their P&L or cash reserves
Avillion will finance 100% of studies within the partnership
Help to accelerate the development of late phase drugs in the pipeline
Provide a team of expert professionals with extensive experience
Why choose Avillion?
Increased shots on goal
Fund phase II and III studies on the registrational path for a specific asset
Expanded geographies
Overcome regional limitations, such as budget constraints or conflicting priorities as a result of lack of expertise or footprint
Broadened pipeline
Finance studies for external assets that are being acquired (M&A) or in-licensed
Networks, focused on execution
Obtain access to broad networks, focused execution and delivery
Ready to take your pharmaceutical project to the next stage?
Latest news
2023
2021
Access global networks
Global staff
presenceGlobal staff
presenceGlobal staff
presenceGlobal staff
presenceWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trials
Global staff
presenceGlobal staff
presenceGlobal staff
presenceGlobal staff
presenceWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trialsWorldwide
clinical trials
